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ABSTRACT
Objectives: To find out the spectrum of clinical presentation and typesof neurodegenerative disorders of childhoodin 
tertiary care child neurology centre of Pakistan. To find out the role of brain imaging in the diagnosis of degenerative brain 
disorders in children. Methods: It will bea retrospective, descriptive study conducted at department of paediatric 
neurology,The Children’s Hospital, Institute of child health, Lahore, Pakistanfrom January 1st,2004 to December 
31,2013 (10 years). A total of 22,737 patients were admitted in the Paediatric Neurology department in the above said 
period. Out of them 366 children fulfilled the inclusion criteria. History, clinical examination and relevant investigations 
were evaluated from the files manually and proformas were filled. Results: Male to female ratio was 1.43:1 with 78% 
incidence of consanguinity. Age range was twenty five months to eighteen years. Metachromatic leukodystrophy was the 
predominant type(21%) followed by adrenoleukodystrophy(1%) and cerebral atrophy (9.5%)and 3% of each Alexander 
disease, Hellervordenspatz disease, one case each of multiple sclerosis and ataxia telangiectasia. Conclusion: Degen-
erative brain diseases are common entity in paediatric population. Commonest presentation is regression of mile stones 
with variable presentation. General pediatriciansmust be aware of their clinical presentation look into it when dealing with 
children having regression of milestones to diagnosethem earlier.Because of limited diagnostic modalities, brain imaging 
has significant valve. Facilities for molecular genetics and enzymes should have been available. Regional diagnostics 
laboratories should have been established and more research is required in this area.
Key Words: Neurodegeneration, Gaucher disease, Metachromaticleukodystrophy, Adrenoleukodystrophy, Alexander 
disease, Canavandisease.
INTRODUCTION
Degenerative brain diseases (DBD) are chronic, progressive 
disorders of brain with invariably fatal outcome (1).Majority 
of these disorders are genetic in nature in which a child 
start regressing milestones (2). Progressive loss of acquired 
milestones are the chief symptoms along with seizures, 
spasticity, feeding difficulties, visual or hearing impairment 
and regression of intellect (3).Neurodegeneration in children 
is increasingly recognized by general practitioners and 
pediatricians because of increasing awareness (4). In the 
young children, they represent an important cause of 
progressive neurological disability. They are frequently 
recognized on MRI, but their identification remains a 
challenge (5). Precisediagnosis is important for prognosis, 
palliative care and possible treatment options. It is also 
mandatory for family screening and genetic counseling 
(6).The diagnostic strategy rests upon clinical clues and MRI 
patterns, complemented by appropriately selected electro-
physiological and laboratory testing. Considerable overlap 
exists between white and gray matter disease, as neuronal 
degeneration will result in myelin loss. An understanding of 
the pathophysiology and natural disease evolution is neces-
sary for the development of treatment modalities (7). Major-
ity of DBD require long term palliative care as many has 
limitedtherapeutic options, sofor the purpose of genetic 
counseling, correct diagnosis is important (8). These 
daysbrain and rectal biopsies are practically not done 
andadvancement in neuroimaging techniques and molecu-
lar genetics has replaced them (9). Pakistan has high birth 
rate and consanguinity is one of the major reason for huge 
burden of inherited neurometabolicdisoders (10).The disease 
is more common than had been previously recognized due 
to phenotypic variability and wide spectrum of presentation. 
Because of poor diagnostic facilities, this condition was not 
well understood (11). We have limitedcommunity based local 
data available to quantify the burden of disease (12). Only 
local data available is from tertiary care hospital (13). This 
study was designed to find out the different types of degen-
erative brain disorders prevalent in our community. Their 
modes of presentation will be evaluated and role of neuro-
imaging will be assessed.
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1 5 V O L .  9  ( 4 )  O C T  -  D E C  2 0 1 4P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S
FIGURE –I
 
MRI BRAIN
Bilateral Hypointence Signals T-I immages
METACHROMATIC LEUKODYSTROPHY
PATIENTS AND METHODS
It is a retrospective, descriptive case study conducted at 
the department of paediatricneurology, Children’s Hospi-
tal and Institute of child health, Lahore, Pakistan. Files of 
all children admitted with regression of milestones on 
history were enrolled in the study.
Inclusion Criteria was: History of regression of acquired 
milestones and age between two years to 18 years. 
Exclusion criteria was: All children having a history 
suggestive of cerebral palsy, neuromuscular disorders, 
hypoxic ischemic encephalopathy, central nervous 
system infections (meningitis, encephalitis, cerebral 
malaria, brain abscess), congenital infections like TORCH 
infections, space occupying lesion of brain or spine, 
progressive hydrocephalus or other problems leading to 
static neurological deficit were excluded. All patients 
presenting to paediatricneurology department fulfilling 
the above cited criteria were included in study. All files of 
admitted patients were evaluated and study performa’s 
were filled manually. Following investigations were done 
during their stay in the ward and entered in the 
performa’s includescomputed tomography (CT scan) of 
brain, magnetic resonance imaging (MRI) [T1, T2 weight-
edand flairs images,in axial,sagital, coronal sections of 
brain and spinal cord where necessary. Electrophysiologi-
cal studies including, nerve conduction velocity and 
electromyography (NCV/EMG), electroencephalography 
(EEG), audiometry, CSF studies (proteins, sugar, anti 
measlesantibodies), fundus examination for optic 
atrophy, pigmentation, slit lamp examination for Keisher-
Fliesher ring, bone marrow examination (where needed) 
and urinary copper estimation (where needed) were 
done.This is an observational study, hence no statistical 
test can be applied.
FIGURE-II
 
MRI BRAIN
Bilateral Posterior Hyperintence Signals
ADRENOLEUKODYSTROPHY
FIGURE-III
 
Flair Axial Images
HELLERVORDEN SPATZ DISEASE 
RESULTS
During the study period,22737 patients were admitted in 
the unit. Initially 678 files were selected with the possible 
diagnosis of DBD, in whom children were presented with 
regression of mile stones. After the detail scrutiny of all the 
files, 366 (1.6%)children qualified the inclusion criteria. 
There were 215(59%) males and 151 (41%) females with 
male to female ration of 1.43:1. The age range was two 
years to 18 years. Mean age of onset of symptoms was 3.8 
years while mean age at diagnosis was 4.7 years. Consan-
guinity among parents was noted in 270(74%) cases and 
history of affected siblings was noted in 117 (32%) cases. 
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Evaluation of different age groups revealed that 96children 
(26%) presented with age less than 5 years, 172 children 
(47%) with age between 5 to 10 years while 98 children 
(27%) were of age above 10 years. Spasticity of varying 
degree was seen in 252 (69%) patients, while ataxia was 
seen in 121(33%) cases. Children presented with speech 
difficulties were 117 (32%), with hearing problem 95 
(26%), with seizures 256 (70%),with visual problems51 
(14%) and 62(17%)patients presented with dystonia. There 
were 7% (26) patients who had epileptic discharges with 
myoclonic jerks on EEG, 70(19%) patients had findings 
suggestive of generalized epileptiform activity and 33 
children (9%) had demyelinating neuropathy on NCVs.
FIGURE-IV
 
CT BRAIN
Bilateral Hypodence Lesions
Involving Frontal Horns White Matter  
ALEXANDER’S DISEASE
Cerebrospinal fluid biochemistry showed elevated proteins 
(50-100 mg/dl) in 175(48%) cases. Metachromatic leukodys-
trophy (figure-I) was the predominant type, seen in 79(21%) 
cases, followed by 72(19%) children with adrenoleukodystro-
phy (figure-II). Brain atrophy (figure-VI) was one of the common 
finding seen in our data with 31 (8.5%) children with cerebral 
atrophy, 12 (3.3%) children with cerebellar atrophy and 19 
(5.2%) children with combined cerebral and cerebellar atrophy. 
It makes the brain atrophy 3rd largest group (62 children / 
17%) after the MLD and ALD. There were 22 (6%) patients 
with the diagnosis of sub acutesclerosingpanencephlitis 
(SSPE), 12 children (3.3%) diagnosed as Wilson Disease, 9 
(2.5%) were diagnosed as Fredrich ataxia. There were 23cases 
(6.3%) of Hellervordenspatz disease (figure-III), 11 (3%) cases 
of Alexander disease (figure-IV), 10 patients (2.7%) were 
diagnosed as canavans disease (figure-VII) and 5 cases(1.4%) 
of multiple sclerosis(figure-V) and 13(3.5%) cases of ataxia 
telangiectasia. Lipidosis was the diagnosis in 4 children (1.1%) 
while Gauchers disease type III was present in 2 cases 
(0.5%).We were unable to make a definitive diagnosis in 21 
(5.7%) children.
FIGURE-V
 
MRI BRAIN 
(Flair Axial Section)
Bilateral Hyperintence Lesions
MULTIPLE SCLEROSIS
DISCUSSION
Childhood neurological disorders are important and frequent 
problems particularly in developing countries, led to signifi-
cant financial burden for the family health care system and 
community. Underlying disorders vary significantly in 
incidence and severity compared to developed countries. 
The outcome will also differ based on early diagnosis, prompt 
effective therapy, rehabilitation and nursing care for the 
survivors. Degenerative brain diseases are growinggroup of 
chronic neurological disorders owing to advancement in MRI 
and in the field of molecular genetics over the recent years 
(14). DBD are caused by mutations in single genes and follow 
mendelian genetics. Currently, genes underlying mendelian 
traits are being discovered rapidly compared with those for 
complex traits (15). Therefore, we expect the number of identi-
fiable degenerative brain diseases to increase in the coming 
years (16). There are few studies done in Pakistan to look into 
the presentation and diagnostic challengesin DBD with small 
samples. If we compare the previous local data of DBD, one 
of the study done in Islamabad concluded that it is really 
difficult to diagnose DBD with limited diagnostic facilities. In 
that study only, one fourth children had been diagnosed 
while majority of children remained under the category of 
unclassified. Leukodystrophies were the commonest diagno-
sis like in our study. Consanguinity was present in majority of 
parents (90%) and it is slightly more common as compared 
to our sample, may be due to different geographical location. 
Thirty eight percent patients had one or more sibs affected 
with similar neurological disorders and it is more or less the 
same finding as in our data (17). MRI of brain is the most 
important test in a patient suspected of having a DBD, which 
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is now widely available in the country.Correlation between 
the MRI brain results with clinical findings may vary, still it is 
believed to be one of the best tool for clinicians (18).
Figure-VI
 
MRI Brain shows Marked Cerebeller Atrophy
Certain patterns of MRI and localizations of lesions is 
crucial in differentiating the metabolic/degenerative 
diseases from inflammatory lesions (19). Evoked poten-
tials and nerve conduction velocities are helpful in differ-
entiating degenerative brain diseases from demyelinat-
ing disorders (20). Patients with X-ALD show normal nerve 
conduction velocities, while patients with metachromatic 
or globoid cell leukodystrophy commonly display abnor-
malities. In Krabbe disease, the severity of abnormalities 
in NCS appears to correlate with clinical severity (21). In 
general, NCS more frequently reveals abnormalities in 
symptomatic patients than evoked responses. In our 
study population, EMG/NCS revealed abnormal findings 
in 47 children, and help us in labeling them as specific 
neurological disorder. Severity of disease revealed in MRI 
correlates with that seen on NCS and clinical data. So 
NCS along withbrain MRI appear to be the most sensi-
tive toolto help in the evaluation of severity and classifi-
cation of globoid cell leukodystrophy (22). Brainstem 
auditory evoked responses (BAER) are usually normal in 
X-ALD during first decade of life but, later become abnor-
mal when demyelination extendsto the brainstem and 
spinal cord. There are 27 children who show abnormal 
findings on the Visual-evoked potentials (VEP). (VEP) in 
X-ALD become abnormal once there are extensive demy-
elinating lesions in the occipital white matter, 
somatosensory-evoked potentials and motor-evoked 
responses even later in the course of the disease (23). 
Children may have an abnormal neurophysiologicalfind-
ings while have normal MRI pattern and hence this 
investigation is more sensitive than brain imaging to 
identify the abnormalities.Usually BAER are first to be 
abnormal, then somatosensory-evoked potential of the 
lower limbs and then motor-evoked responses to lower 
limbs (24).
Figure- VII
MRI Brain shows marked demyelination in Canavansleu-
kodystrophy
In another study done in pediatric department of 
postgraduate medical institute, Lahore, it is concluded 
that 6.7% children (408/6089) were admitted with neuro-
logical disorders with male predominance (61.7%). These 
results were comparable with the current study in many 
respects though the objectives were different from our 
study.  Degenerative brain disorders were one of the 
commonest subgroup among the neurological disorders 
with highest case fatality rates (30.4%). Childhood neuro-
logical disorders in developing countries cause significant 
morbidity and end up as high case fatality. Congenital and 
perinatal problems, infections of the brain, tumors of brain 
and epilepsy constitute major burden. Simple measures 
like mass immunizations, good antenatal and postnatal 
care and improved rehabilitation services can reduce the 
burden of neurological diseases and outcome (25). Labora-
tory tests should have been ordered afterthorough evalua-
tion of clinical and imaging findings as they are frequently 
of low yield and cause high costs (26). The utility of 
individual tests is established through the findings on a 
focused clinical examination and suspicion arising from an 
analysis of the imaging pattern (27). A number of tests that 
may be useful to do relatively early in the diagnostic 
process include those listed in the table-I. Previous 
published local data suggests the huge burden of disease 
but due to lack of diagnostic facilities in developing coun-
tries, limited progress has been done. Now with the 
access of neurophysiology, neuroimaging and some of the 
relevant enzymatic studies, DBD can be diagnosed and 
differentiated from other conditions. Lack of awareness at 
primary care level and limited diagnostic facilities may led 
to either delayed diagnosis or wrong diagnosis (28). Parents 
who had one or more affected children were swifter to 
recognize abnormality in subsequent children. EEG was 
suggestive of non-specific seizure discharges in 21 (31%) 
patients. Nerve conduction velocity demonstrated marked 
decrease of nerve conduction velocities, both motor and 
sensory, suggestive of demyelinaging neuropathy in 19 
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(29%). MLD was the predominant type of leukodystrophy 
seen in our study with 14 (21%) children, the other rare 
types were also seen like Alexander disease 2 (3%). Com-
parable results were described another local data by 
Matloob Azam (17). DBD are one of the major problems in 
child neurology with significant financial burden on the 
families and health care system due to delay in diagnosis. 
Brain imaging (CT brain: 34 cases and MRI brain:5 cases) 
was taken as tool to evaluate 39 children with progressive 
neurological disorders. Results showed abnormal findings 
in 33 children (27 cases) in CT brain and 3 cases of MR 
brain. Radiological interpretation reveals demyelination, 
cortical atrophy/ cerebellar atrophy, calcification, hyper-
dence areas or hypodence areas of cerebrum. It was 
concluded in the study that MRI or CT scan brain should 
be part of evaluation of a child in some kind of neurode-
generative disorder is suspected (29). Neuro degenerative 
disorders are progressive disorders with significant morbid-
ity and mortality with adverse socioeconomic impact on 
the family. They require thorough work up once they are 
suspected. Multidisciplinary approach and genetic coun-
seling must be offered to every confirmed case. Health 
education regarding the immunization can decrease high 
incidence of SSPE (30). Over the past three decades, Paedi-
atric Neurology has made lot of progress. It is a dynamic 
field and offering a new ray of hope to most of the neuro-
logical patients (31). Despite the fact that there is a big 
number who has this group of huge number of children, 
there is no facility for enzyme studies all our Pakistan. 
Simple measure like treatment of spasticity, control of fits, 
preventing bed sores, regular physiotherapy, providing 
them mobility aids, treatment of infections, care of 
nutrition and anemia, audiological and ophthalmologic 
assistance may improve their quality of life (32).
CONCLUSION
DBD are common neurological disorders in the children 
of developing countries. Their clinical presentation is 
variable and brain imaging is very helpful in diagnosis. 
Facilities for molecular genetics and enzymes should be 
available in tertiary care paeditric hospitals and special-
ized regional centers should be established.
Table 1: Spectrum of Investigations 
(n=366)
Table 2: Spectrum of Diagnosis
(n=366)
REFERENCES
1. Fenichel GM.Psychomotor retardation and regression 
 In:Clinical paediatricPaediatric Neurology. 7th Edition
 2013. WB SaundresUSA.117-47.
2. Azam M. Degenerative brain disease and neuroimaging 
 in children. J Coll Physicians Surg Pak 1999;9 (3): 
 127-31.
3. Perey AK. Inherited neurodegenerative diseases.
 The evolution of our thinking. J. Child Neurol
 1999; 12:256-62.
4. Afzal M, Shahid M. Children presenting with
 seizures-A hospital based study. J Coll Physicians
 Surg Pak 1999;9 (3):132-5.
5. Alan Jackson. Neurodegenerative and white
 matter disease. In:James E. Gillespie, Alan Jackson
 (edi).MRI and CT of the brain. New York:Arnold
 publishers 2000;241-165.
6. Kaye EM, Update on genetic disorders affecting
 white matter. PediatrNeurol 2001 Jan; 24(1):11-24.
7. Arbout LT, Sliver K, Hetatman P, Treacy EP, Variable
 onset of metachromatic leukodystrophy in a
 Vietnamese family. PediatrNeurol 2000 Aug;
 23(2):173-6.
8. Krivit W, Aubourg P, Shapiro E, Peters C: Bone
 marrow transplantation for globoidcell leukodystrophy,
 adrenoleukodystrophy, metachromatic leukodys-
 trophyand Hurler syndrome. Cur OpinHematol
 1999 Nov 6(6): 377-82. 
9. Berger J, Moser HW, Forss-Petter S: Degenerative
 brain diseases: Recent developments in genetics,
 molecular biology, pathogencesis and treatment.
 CurrOptinNeurol 2001; 14:305.
10. Ahmad I,Yasin F, Iqbal K. Diagnosis of storage 
 diseases in children by bone marrow examination.
 Pakistan Ped J 1995; 19 (1):15-7.
11. Sultan T, Zuberi S, Mcwilliam R. Paediatric Neurology 
S.No Name of Investigation Number Percentage 
 MRI Brain 344 94% 
 CT Brain 336 92% 
 Electroencephalogram 366 100% 
 NCS/EMG 205 56% 
 Audiometry 70 19% 
 CSF Examination 318 87% 
 Fundoscopy / Slit lamp examination 238 65% 
 Visual Evoked Potentials 11 03% 
 Bone Marrow examination 14 04% 
01
02
03
04
05
06
07
08
09
S.No Name of Disease Number Percentage 
 Metachromatic leukodystrophy (MLD) 79 21% 
 Adrenoleukodystrophy (ALD) 72 19.7% 
 Cerebral atrophy 31 8.5% 
 Haller Worden Spatz Disease 23 6.3 % 
 Sub acutesclerosingpanencephlitis (SSPE) 22 6 % 
 Familial spastic paraplegia 21 5.7% 
 Cerebral and Cerebeller atrophy 19 5.2 % 
 Ataxia telangiectasia 13 3.5 % 
 Wilson Disease 12 3.3 % 
 Cerebeller atrophy 12 3.3 % 
 Alexander Disease 11 3 % 
 Canavans disease  10 2.7 % 
 Friedreich ataxia 9 2.5% 
 Multiple Sclerosis 5 1.4 % 
 Lipidosis 4 1.1 % 
 Gaucher Disease Type III 2 0.5 % 
 Unclassified 21 5.7 % 
 Total 366  
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
1 9 V O L .  9  ( 4 )  O C T  -  D E C  2 0 1 4P A K I S T A N  J O U R N A L  O F  N E U R O L O G I C A L  S C I E N C E S
 training- A developing country perspective. J Coll 
 Physicians Surg Pak 2006;16(7):282.
12. Schiffmann R, van der Knaap MS. an MRI-based 
 approach to the diagnosis of white matter disorders.
 Paediatric Neurology2009; 72(8),750-59.
13. Steenweg ME, Vanderver A, Blaser S. Magnetic
 resonance imaging pattern recognition in hypomy-
 elinating disorders. Brain2010; 133(10),2971-82.
14. Lin J, Faria EC, Da Rocha AJ. Leukoencephalopathy
 with brainstem and spinal cord involvement and 
 normal lactate: a new mutation in the DARS2
 gene. J. Child Neurol 2010;25(11),1425-28. 
15. Jose RA, Tulio BF, Carlos MMA Jr.  Lactate detection
 by MRS in mitochondrial encephalopathy: optimization
 of technical parameters. J. Neuroimaging 2008;
 18(1),1-8. 
16. Loes DJ, Fatemi A, Melhem ER. Analysis of MRI 
 patterns aids prediction of progression in X-linked
 adrenoleukodystrophy. Paediatric Neurology 2003;
 61(3),369-74.
17. Azam M. Neurodegenerative diseases of infancy
 and childhood. Pak J Pathol 1996:7(3):111-8.
18. Provenzale JM, Peddi S, Kurtzberg J, Poe MD,
 Mukundan S, Escolar M. Correlation of neurode-
 velopmental features and MRI findings in infantile
 Krabbe’s disease. Am. J. Roentgenol.2009;
 192(1),59-65.
19. Eichler F, Grodd W, Grant E et al. Metachromatic
 leukodystrophy: a scoring system for brain MR
 imaging observations.  Am. J. Neuroradiol.2009;
 30(10),1893-97.
20. Husain AM, Altuwaijri M, Aldosari M. Krabbe
 disease: neurophysiologic studies and MRI correlations.
 Paediatric Neurology 2004; 63(4),617-20.
21. van der Knaap MS, Pronk JC, Scheper GC. Vanishing
 white matter disease. Lancet Neurol.2006; 5(5), 
 413-23.
22. Siddiqi ZA, Sanders DB, Massey JM. Peripheral
 neuropathy in Krabbe disease: electrodiagnostic
 findings. Paediatric Neurology 2006; 67(2),263-67.
23. Moser HW, Raymond GV, Dubey P. Adrenoleukod-
 ystrophy: new approaches to a neurodegenerative
 disease. JAMA2005;294(24),3131-34.
24. Dubey P, Raymond GV, Moser AB, Kharkar S,
 Bezman L, Moser HW. Adrenal insufficiency in
 asymptomatic adrenoleukodystrophy patients
 identified by very long-chain fatty acid screening.
 J. Pediatr.2005 146(4),528-32. 
25. Zaheer A, Rashid A, Chishty AL. Neurological
 disease spectrum and associated factors for 
 morbidity and mortality among admitted children.
 Pak Paed J 2009;33(1):24-9.
26. Laureti S, Casucci G, Santeusanio F, Angeletti G, 
 Aubourg P, Brunetti P. X-linked adrenoleukodystrophy
 is a frequent cause of idiopathic Addison’s disease in
 young adult male patients. J. Clin. Endocrinol. Metab.
 1996;81(2),470-74.
27. Klick JC, Hauer J. Pediatric palliative care. Curr.
 Probl. Pediatr. Adolesc. Health Care 2010; 40(6), 
 120-51. 
28. Hauer JM, Wical BS, Charnas L. Gabapentin 
 successfully manages chronic unexplained irritability 
 in children with severe neurologic impairment.
 Pediatrics 2007;119(2),519-22. 
29. Azam M. Degenerative brain diseases and neuro-
 imaging in children. J Coll Physicians Surg Pak 
 1999;9(3):127-31.
30. Azam M, Bhatti N, Krishin J, Hazir T. Subacutes-
 clerosingpanencephalitis. J Pakistan Inst Med Sci
 2002;13(1): 618-22. 
31. Moser HW, Raymond GV, Lu SE et al. Follow-up of
 89 asymptomatic patients with adrenoleukodys-
 trophy treated with Lorenzo’s oil. Arch. Neurol. 
 2005; 62(7),1073-80. 
32. Shafqat S, Wasay M. Paediatric Neurology in the
 21st Century: Contemporary state of diagnostics
 and therapeutics. J Pak Med Assoc 2004; 54 (5):
 271-6.
Conflict of interest: Author declares no conflict of interest.
Funding disclosure: Nil
Author’s contribution:
Dr. Tipu Sultan: Study concept and design, protocol writing, data collection, data analysis, manuscript writing, manuscript review
Dr. Ashfa Ameer Khan: Study concept and desig, data collection, data analysis, manuscript writing, manuscript review
Dr.Muhammad Arshad Khawaja: data collection, data analysis, manuscript writing, manuscript review
Dr. Ziaur Rahman: manuscript writing, manuscript review
Dr. Ahsan waheed Rathore: data analysis, manuscript writing, manuscript review
